BEAM
NASDAQ HealthcareBeam Therapeutics Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $25.59 |
|---|---|
| Volume | 2,684,326 |
| Market Cap | 2.61B |
| Beta | 2.170 |
| RSI (14-Day) | 43.9 |
| 200-Day MA | $23.46 |
| 50-Day MA | $28.65 |
| 52-Week High | $36.44 |
| 52-Week Low | $13.53 |
| Forward P/E | -5.97 |
| Price / Book | 2.05 |
🎯 Investment Strategy Scores
How BEAM scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
4/100
High dividend yield + low volatility
🚀 Moon Shot
93/100
High growth potential (high beta + oversold)
🔪 Falling Knife
32/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
61/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
46/100
Large-cap, institutional-quality stocks
Find BEAM in your text
Paste any text on the homepage — the tool will extract BEAM and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.